We are live on ! Find out more
CS

Candriam SCA Portfolio holdings

AUM $19.3B
1-Year Est. Return 39.18%
This Fund
S&P 500
This Quarter Est. Return
-4.69%
1 Year Est. Return
+39.18%
3 Year Est. Return
+109.85%
5 Year Est. Return
+149.31%
10 Year Est. Return
+617.16%
AUM
$14.7B
AUM Growth
-$972M
Cap. Flow
+$106M
Cap. Flow %
0.72%
Top 10 Hldgs %
23.63%
Holding
875
New
75
Increased
357
Reduced
296
Closed
67

Top Buys

Rank Stock Value
1
DIS icon
Walt Disney
DIS
+$90.2M
2
MRK icon
Merck
MRK
+$70M
3
ADBE icon
Adobe
ADBE
+$55.1M
4
BKNG icon
Booking.com
BKNG
+$34.5M
5
NOW icon
ServiceNow
NOW
+$30.3M

Top Sells

Rank Stock Value
1
AMGN icon
Amgen
AMGN
+$51.3M
2
VRTX icon
Vertex Pharmaceuticals
VRTX
+$40.4M
3
CRM icon
Salesforce
CRM
+$36.7M
4
INFO
IHS Markit Ltd. Common Shares
INFO
+$36.4M
5
ARNA
Arena Pharmaceuticals Inc
ARNA
+$30.1M

Sector Composition

Rank Sector Weight
1 Healthcare 29.35%
2 Technology 26.36%
3 Financials 8.78%
4 Communication Services 7.85%
5 Consumer Discretionary 7.81%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
DXCM icon
226
DexCom
DXCM
$29B
$12.3M 0.08%
96,128
-12,848
-12% -$1.41M
REG icon
227
Regency Centers
REG
$14.9B
$12.2M 0.08%
171,335
+111,225
+185% +$7.78M
CAT icon
228
Caterpillar
CAT
$361B
$12.2M 0.08%
54,529
-212
-0.4% -$44.5K
TREX icon
229
Trex
TREX
$4.4B
$12.1M 0.08%
185,807
+47,368
+34% +$4.22M
EQR icon
230
Equity Residential
EQR
$25.8B
$12.1M 0.08%
134,751
-63,552
-32% -$5.61M
BPMC
231
DELISTED
Blueprint Medicines
BPMC
$12.1M 0.08%
189,441
-162,802
-46% -$11.7M
ORCL icon
232
Oracle
ORCL
$339B
$12.1M 0.08%
145,905
-1,340
-0.9% -$109K
ZS icon
233
Zscaler
ZS
$24.9B
$11.8M 0.08%
48,903
+16,184
+49% +$3.98M
DD icon
234
DuPont de Nemours
DD
$18.6B
$11.7M 0.08%
126,286
-15,910
-11% -$1.55M
CERN
235
DELISTED
Cerner Corp
CERN
$11.6M 0.08%
124,491
+9,122
+8% +$844K
UMPQ
236
DELISTED
Umpqua Holdings Corp
UMPQ
$11.6M 0.08%
615,803
+52,871
+9% +$1.08M
BNY
237
Bank of New York Mellon
BNY
$103B
$11.5M 0.08%
232,115
+81,728
+54% +$4.65M
T icon
238
AT&T
T
$164B
$11.3M 0.08%
631,020
+33,137
+6% +$613K
RVMD icon
239
Revolution Medicines
RVMD
$38.5B
$11.1M 0.08%
434,204
-16,178
-4% -$352K
MAT icon
240
Mattel
MAT
$4.47B
$11M 0.07%
495,735
-39,281
-7% -$898K
WAB icon
241
Wabtec
WAB
$49.3B
$10.9M 0.07%
113,569
+15,861
+16% +$1.47M
NRIX icon
242
Nurix Therapeutics
NRIX
$2.45B
$10.7M 0.07%
765,106
-28,997
-4% -$515K
TD icon
243
Toronto Dominion Bank
TD
$193B
$10.7M 0.07%
134,572
+27,712
+26% +$2.23M
FOE
244
DELISTED
Ferro Corporation
FOE
$10.7M 0.07%
491,298
+272,049
+124% +$5.91M
DOCU
245
DocuSign
DOCU
$11.1B
$10.5M 0.07%
97,680
+21,521
+28% +$2.47M
MCO icon
246
Moody's
MCO
$83.7B
$10.5M 0.07%
30,994
+684
+2% +$230K
VCYT icon
247
Veracyte
VCYT
$4.45B
$10.4M 0.07%
+378,663
New +$10.8M
RMD icon
248
ResMed
RMD
$31.1B
$10.4M 0.07%
42,895
-20,337
-32% -$4.92M
KR icon
249
Kroger
KR
$36.7B
$10.3M 0.07%
180,307
-41,651
-19% -$2.07M
ZBH icon
250
Zimmer Biomet
ZBH
$18.8B
$10.3M 0.07%
80,716
-2,649
-3% -$319K
8 9
10
11 12

Similar funds

PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
A
AustralianSuper Melbourne, Australia $19.2B AUM 31.95% 1-Year Est. Return
MGP
M&G plc London, United Kingdom $19.4B AUM 16.7% 1-Year Est. Return
LF
Lansforsakringar Fondforvaltning Stockholm, Sweden $19.1B AUM 26.9% 1-Year Est. Return
Select Equity Group
Select Equity Group New York $19.5B AUM 17.33% 1-Year Est. Return
SOMRS
State of Michigan Retirement System Lansing, Michigan $18.9B AUM 27.96% 1-Year Est. Return
BPA
Beacon Pointe Advisors Newport Beach, California $18.9B AUM 18.9% 1-Year Est. Return
MIM
MetLife Investment Management Whippany, New Jersey $19.6B AUM 32.64% 1-Year Est. Return

Candriam SCA's Q1 2022 Portfolio in Review

As of Q1 2022, Candriam SCA held 875 positions worth $14.7B, down 6.2% from $15.7B the previous quarter. Its ten largest holdings account for 24% of the portfolio.

Candriam SCA's Q1 2022 filing shows 75 new, 357 increased, 296 reduced and 67 closed positions. Its largest new stake was Ecopetrol: 1,389,000 shares worth $25.8M. The largest sale was Amgen, an estimated $51.3M.

By sector, the portfolio is most concentrated in Healthcare at 29% of assets, down from 31% a quarter earlier, followed by Technology and Financials.

  • Candriam SCA's largest Q1 2022 buy was Ecopetrol: 1,389,000 shares worth $25.8M.
  • Candriam SCA added most to Walt Disney in Q1 2022, an estimated $90.2M increase.
  • Candriam SCA's biggest Q1 2022 reduction was Amgen, cutting an estimated $51.3M.
  • Candriam SCA fully exited IHS Markit Ltd. Common Shares in Q1 2022, selling an estimated $36.4M.
  • Candriam SCA's ten largest holdings make up 24% of its $14.7B portfolio in Q1 2022.
  • Candriam SCA opened 75 new positions and closed 67 in Q1 2022.
  • Candriam SCA's portfolio value fell 6.2% quarter-over-quarter to $14.7B.

Based on Candriam SCA's 13F filing for Q1 2022, filed 13 May 2022.